WILMINGTON, Mass.--(BUSINESS WIRE)--Jan 9, 2023--

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10 th, at 10:30 a.m. PST (1:30 p.m. EST). Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230106005376/en/

CONTACT: Investor Relations Contact:

Todd Spencer

Corporate Vice President, Investor Relations

781.222.6455

todd.spencer@crl.com

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES HEALTH PHARMACEUTICAL

SOURCE: Charles River Laboratories International, Inc.

Copyright Business Wire 2023.

PUB: 01/09/2023 04:15 PM/DISC: 01/09/2023 04:17 PM

http://www.businesswire.com/news/home/20230106005376/en